Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
This piece highlights Which Dividend Fund Charges Least Fees and the factors to consider when evaluating expense structures.
23,858 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
The SEC approves WisdomTree's request for exemptive relief, unlocking 24/7 trading and near-instant settlement for to...
Top U.S. homebuilders are backing Avila Real Estate Capital’s AREC Fund II, signaling a shift in housing finance as b...
AMZY, the YieldMax AMZN Option Income Strategy ETF, uses a synthetic covered-call approach to generate monthly distri...
A biotech stock has surged 355%, catching the eye of every investor from day traders to pension funds. A prominent he...
Investors targeting higher income are turning to closed-end funds trading at discounts to NAV, seeking a compelling y...
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
An equal-weight large-cap ETF is gaining attention as a retirement-friendly alternative to cap-weighted funds. Here’s...
The iShares Semiconductor ETF surged in the first half of 2026, powered by AI infrastructure demand and a rebound in ...
MGK's gains have been propelled by a tight core of five megacaps, a dynamic that boosts returns but also raises risk ...
A major fund stepped in with a bold $30 million wager on Floor & Decor after a sharp 30% decline. This article breaks...
A little-known income ETF has doubled this year by selling covered calls on AMD, outperforming the broad market as th...